Results: 4

1.
Figure 1.

Figure 1. From: A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis.

Enrollment and outcomes. IPF = idiopathic pulmonary fibrosis.

Imre Noth, et al. Am J Respir Crit Care Med. 2012 July 1;186(1):88-95.
2.
Figure 3.

Figure 3. From: A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis.

Mortality listing with clinical events. IPF = idiopathic pulmonary fibrosis.

Imre Noth, et al. Am J Respir Crit Care Med. 2012 July 1;186(1):88-95.
3.
Figure 4.

Figure 4. From: A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis.

Subgroup analysis of the key clinical subgroups. DlCO = diffusing capacity of carbon monoxide.

Imre Noth, et al. Am J Respir Crit Care Med. 2012 July 1;186(1):88-95.
4.
Figure 2.

Figure 2. From: A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis.

(A) Comparison of warfarin with placebo for the primary endpoint. (B) Comparison of warfarin versus placebo for time to all-cause mortality. (C) Comparison of warfarin versus placebo for time to all-cause mortality or all-cause hospitalization.

Imre Noth, et al. Am J Respir Crit Care Med. 2012 July 1;186(1):88-95.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk